InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the detailed record of transactions filed by Farnum Rhonda, Directrice Exécutive et Responsable des Affaires Médicales. Officer active across 1 companies, notably Theravance Biopharma, Inc.. Aggregated, 5 reports have been recorded. Total volume traded: €21k. The latest transaction was filed on 20 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€18,1762,200 shares@ €8.26170.0022% mcap13.0% of flow
Ordinary Shares
SEC:0001415889-22-005627:0·
€21,4172,356 shares@ €9.09050.0026% mcap15.3% of flow
Ordinary Shares
SEC:0001415889-22-002174:0·
€99,96811,824 shares@ €8.45470.012% mcap71.6% of flow
Ordinary Shares
SEC:0001415889-22-001695:0·
027,500 shares0
Ordinary Shares
SEC:0001179110-21-011076·
027,500 shares0
Ordinary Shares
SEC:0001179110-21-011076:0·
5 of 5 declarations
About Farnum Rhonda
Rhonda Farnum serves as Executive Vice President and Chief of Communications & Medical Affairs at Theravance Biopharma, Inc. She oversees operations related to medical affairs and communications. Her role is essential to ensure compliance and effectiveness of the company's medical initiatives.
